# Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics

> **NCT00870012** · NA · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 20 (actual)

## Conditions studied

- Nonalcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Lepicol probiotic & prebiotic formula
- **OTHER:** Simple lifestyle advice

## Key facts

- **NCT ID:** NCT00870012
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870012, "Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00870012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*